dihydroxyphenylalanine has been researched along with norbinaltorphimine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
LaVigne, SD; Lookingland, KJ; Manzanares, J; Moore, KE; Wagner, EJ | 1 |
LaVigne, SD; Lookingland, KJ; Manzanares, J; Moore, KE | 1 |
Durham, RA; Johnson, JD; Lookingland, KJ; Moore, KE | 1 |
3 other study(ies) available for dihydroxyphenylalanine and norbinaltorphimine
Article | Year |
---|---|
Sexual differences in kappa opioid receptor-mediated regulation of tuberoinfundibular dopaminergic neurons.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Arcuate Nucleus of Hypothalamus; Dihydroxyphenylalanine; Dopamine; Female; Male; Median Eminence; Naltrexone; Narcotic Antagonists; Neurons; Orchiectomy; Ovariectomy; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Sex Characteristics; Tuber Cinereum | 1992 |
Activation of tuberohypophysial dopamine neurons following intracerebroventricular administration of the selective kappa opioid receptor antagonist NOR-binaltorphimine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Hydrazines; Injections, Intraperitoneal; Male; Naltrexone; Narcotic Antagonists; Neurons; Nucleus Accumbens; Pituitary Gland; Pituitary Gland, Posterior; Rats; Receptors, Opioid, kappa | 1991 |
Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Afferent Pathways; Analgesics; Animals; Cerebral Ventricles; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Dopamine Agonists; Dynorphins; Hypothalamus; Hypothalamus, Middle; Injections, Intraperitoneal; Injections, Intraventricular; Limbic System; Male; Median Eminence; Naltrexone; Narcotic Antagonists; Neurons; Nucleus Accumbens; Prolactin; Pyrrolidines; Quinolines; Rats; Receptors, Dopamine D2; Receptors, Opioid, kappa | 1996 |